Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1988 | 12-1987 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 360,784 | N/A |
| Marketable Securities | 2,241,135 | N/A |
| Receivables | 1,395,923 | N/A |
| Inventories | 1,308,439 | N/A |
| Other current assets | 305,876 | 0 |
| TOTAL | $5,612,157 | $N/A |
| Non-Current Assets | ||
| PPE Net | 4,890,885 | N/A |
| Investments And Advances | 62,664 | 0 |
| Other Non-Current Assets | 26,811 | 0 |
| TOTAL | $4,980,360 | $N/A |
| Total Assets | $10,622,740 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 83,258 | N/A |
| Accounts payable and accrued liabilities | 508,334 | 0 |
| Other current liabilities | 647,629 | N/A |
| TOTAL | $3,192,211 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 1,112,139 | N/A |
| aiOther Non-Current Liabilities | 131,643 | 0 |
| TOTAL | $1,243,782 | $N/A |
| Total Liabilities | $4,426,412 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 509,744 | N/A |
| Retained earnings | 3,977,452 | N/A |
| Other shareholders' equity | 1,675,548 | 0 |
| TOTAL | $6,162,744 | $N/A |
| Total Liabilities And Equity | $10,589,156 | $0 |